News & Investors
News
Lumicell Supports Stand Up To Cancer Dream Team for Early Detection of Gastric Cancer with Investigational Device and New Drug
Global Team Will Launch Gastric Cancer Prevention Clinical Trial. CAUTION – Investigational device and new drug. Limited by Federal (or United States) law to investigational use.
- Los Angeles
- January 8, 2026
Feasibility Study Underway to Assess Lumicell Technology for Removing Ovarian and Peritoneal Cancer Tumors During the First Surgery
Positive Clinical Results in Breast Cancer Trial Shows Promise for Ovarian and Other Cancers Newton, Mass., April 10, 2019 — Lumicell, Inc. today announced that a feasibility study is underway at Massachusetts General
Lumicell Headquarters Expands Into New Boston-Area Office Space
New location offers more space for expansion and designed to inspire innovation of Lumicell technology through further employee collaboration Newton, Mass., Feb. 22, 2019— Lumicell, Inc., an innovation leader in
Lumicell Presents Phase 2 Clinical Data Showing LUM System Provided
Complete and Immediate Detection of Residual Cancer in Tumor Cavity During Lumpectomy Surgery Data Presented by Investigators from Massachusetts General Hospital’s Breast Program at 2017 San Antonio Breast Cancer Symposium Integrated LUM System Correctly Identified
Lumicell Expands Development Strategy and Pipeline Across Five Solid Tumor Cancers Supported by $28.7 Million Series C Financing
Proceeds to Fund Pivotal Trial in Breast Cancer Leverages Broad Potential of LUM System with Drug, Device and Software for Real-time Detection of Tumor Tissue in Patients During Surgery Wellesley, Mass.,
Lumicell Initiates New Clinical Studies in Breast Cancer and Prostate Cancer with LUM System for Real-time Detection of Tumor Tissue in Patients During Surgery
Company receives FDA Approval to initiate multiple IDE studies, Including Path to Pivotal Trial in Breast Cancer Integrated LUM System with Drug, Device and Software Currently Under Investigation in Five
Lumicell to Participate in Upcoming Conferences
Wellesley, Mass., September 5, 2017— Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, announced today that management will participate in two upcoming September meetings, including: “We
Lumicell Announces Product Development Progress with LUM015 in Lumicell System for Image-guided Cancer Surgery
Product innovation continues to advance under scientific leadership of company’s founder, W. David Lee Wellesley, Mass., Aug. 10, 2017— Lumicell, Inc., a technology leader in the field of image-guided cancer
Lumicell Appoints Kelly Londy as Chief Executive Officer, Announces Additional Financing
Wellesley, Mass., July 12, 2017 – The Board of Directors of Lumicell, Inc., a leader in the field of image-guided cancer surgery, announced today the appointment of Kelly Londy as Chief
Lumicell Appoints Felix Geissler, M.D., Ph.D. as Chief Medical Officer
Wellesley, Mass., June 28, 2017 – Lumicell, a leader in the field of image-guided cancer surgery, today announced the appointment of Felix Geissler, M.D., Ph.D. as Chief Medical Officer. As a central
Events
San Antonio Breast Cancer Symposium®,
December 10-14, 2024
Henry B. Gonzalez Convention Center
Investors
